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Abstract International advocacy of patient-centred
healthcare delivery has led to emphasis on the (re)design
and evaluation of healthcare processes and outcomes from
a patient perspective. Patient-reported outcome measures
(PROMs) have significant potential to inform such at-
tempts. However there is limited understanding of the pro-
cesses by which this can be achieved. This exploratory
study followed attempts to utilise two different PROMs
measures to support service quality improvement in clini-
cal genetics. PROMs used were the Genetic Counseling
Outcome Scale (GCOS-24), a well-validated clinical
genetics-specific PROM and Euroqol (EQ-5D), a generic
PROM favoured by the UK National Institute for Health
and Excellence (NICE). Both of these PROMs enable
pre/post intervention comparison. A service audit tool
was also used, premised on a patient-reported experience
measure. In addition, the study draws on interviews with
clinical staff to identify challenges associated with the use
of PROMs (response rate, data collection, analysis).
Benefits are also explored and include the provision of
insight into patients’ needs; complementing clinical
judgement; identification of needs being met, evidencing
the benefit of services provided; prompting consideration
of areas requiring attention; and encouraging professional
development.
Keywords Patient-reported outcomemeasures (PROMs) .
Quality improvement . Clinical genetics . Exploratory
Introduction
Healthcare quality improvement refers to “designing and
redesigning work processes and systems that deliver
healthcare with better outcomes and lower cost” (Ham et al.
2016 p3). In the UK – and more broadly - there are two
approaches to this: the centralised approach, emphasising reg-
ulation and inspection of providers, and the devolved ap-
proach in which healthcare quality improvement initiatives
are led by local clinicians. Both approaches can incorporate
use of patient-reported outcomes (Darzi 2008; Dawson et al.
2010; Leatherman and Sunderland 2008), enabling alignment
with an international shift towards emphasising patient-
centred healthcare delivery. For example, in 2008, the World
Health Organization (WHO) reported that healthcare services
should be more patient-centred (WHO 2008). The WHO
claims that patients want more from healthcare than simply
medical interventions, arguing that “People-centeredness is
not a luxury, it is a necessity” (WHO 2008, p. 16). In the
UK context of this study, the Department of Health (DH)
published guidance in 2010, which mandated that the UK
National Health Service (NHS) become more patient-centred.
This guidance highlighted the importance of sharing decision-
making between patients and professionals, with evaluation of
patients’ perspectives important in this process (DH 2010).
One way of assessing patients’ perspectives is using patient-
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reported outcome measures (PROMs). This is evident inter-
nationally, including in the USA, as exemplified by the
National Institute of Health-funded Patient-Reported
Outcome Measures Information Systems initiative
(Ader 2007).
PROMs are short questionnaires completed by patients
for assessment of health and health-related quality of life
outcomes. PROMs were traditionally used in the context
of clinical trials, but are increasingly being used to evaluate
routine healthcare (Appleby and Devlin 2004; Dawson et al.
2010). PROMs data are collected directly from patients,
without clinician interpretation, and paying attention to
PROMs data is considered important for delivery of
patient-centred care (Appleby and Devlin 2004; Dawson
et al. 2010). Ideally, PROMs data are collected before and
after healthcare service use, so that change in patient-report-
ed outcomes (PROs), attributable to the service or interven-
tion received, can be identified (Appleby and Devlin 2004;
Dawson et al. 2010). This provides an assessment of wheth-
er the patient feels better, and how much better. A combina-
tion of a generic and a condition-specific or speciality-
specific PROM is considered optimal because, although
the latter have greater face validity and credibility, generic
PROMs enable comparisons across conditions (Black 2013;
Devlin and Appleby 2010). It has been suggested that
PROMs data could be used to transform how healthcare is
organised and delivered (Black 2013), and to manage
healthcare performance by feeding PROMs data back to
the providers (Appleby and Devlin 2004; Haywood et al.
2006). In a related vein, healthcare teams are beginning to
use PROMs data to improve the quality of care (Boyce et al.
2014). However, despite evidence that PROMs use is ac-
ceptable to patients, can enable earlier symptom detection,
and may improve clinician-patient communication, there is
little understanding regarding how this may occur, and def-
inite evidence that PROMs data can be used by clinicians to
achieve service quality improvements that improve PROs
and other outcomes is lacking (Chen et al. 2013; Howell
et al. 2015). Nevertheless, there has been some suggestion
that PROMs data, used as a management tool with special-
ized patient populations in an outpatient setting, could result
in better outcomes for patients (Boyce and Browne 2013).
As a consequence there may be some benefit in exploring
this approach in a UK genetic counseling context, where it is
delivered as part of specialized outpatient care.
The aim of this study is to explore the benefits of, and
challenges to, using PROMs for service quality improve-
ment in clinical genetics. This is achieved through a case-
study of a local clinician-led service quality improvement
initiative. The PROMs chosen were the generic Euroqol
(EQ-5D) (Euroqol Group 2009) and the clinical genetics-
specific Genetic Counseling Outcome Scale (GCOS-24)
(McAllister et al. 2011), along with an audit tool
(Skirton et al. 2005). Of particular note is the use of
GCOS-24 in service evaluation exercises in six of the 25
UK regional clinical genetics centres in 2011–12
(McAllister 2016). Findings demonstrated that (i) NHS
clinical genetics services can deliver significant measur-
able patient benefits and (ii) GCOS-24 has potential to
generate information about routine NHS clinical genetics
pract ice that may be useful to decis ion-makers
(McAllister 2016). However, these exercises also identi-
fied the need for significant further work including the
need to develop an approach to support clinical teams to
use PROMs data effectively to contribute to a continuous
quality improvement cycle focused on optimising patient
benefits (McAllister 2016), as explored here.
Methods
A combination of quantitative and qualitative methods was
used. All procedures followed were in accordance with the
ethical standards of the responsible committees on human
experimentation (institutional and national) and with the
Helsinki Declaration of 1975, as revised in 2000 (5).
Informed consent was obtained from all patients for being
included in the study.
Quantitative Instrumentation
Three quantitative data collection instruments were uti-
lized in the study. First, EQ-5D (See Supplement A) was
chosen because it is the generic PROM favoured by the
UK National Institute for Health and Excellence (NICE),
a public body of the DH whose remit is evaluation of the
efficacy and cost-effectiveness of interventions carried out
by the NHS (NICE 2014). EQ-5D is favoured by NICE
because it can be used to calculate Quality Adjusted Life
Years and can therefore be used in economic evaluations
of health interventions (Phillips 2009). EQ-5D captures
five domains of health: mobility, self-care, usual activi-
ties, pain/discomfort and anxiety/depression (Euroqol
Group 2009). The minimum score for EQ-5D is 5 and
the maximum score is 25.
Second, GCOS-24 was chosen because it is a well-
validated clinical genetics-specific PROM with proven va-
lidity, reliability and responsiveness to change over time
(McAllister et al. 2011) (See Supplement B). GCOS-24
captures empowerment, a construct summarising patient
benefits from using clinical genetics services (genetic test-
ing and counseling) comprising five dimensions: cognitive
control (having sufficient knowledge and understanding
about the condition, signs and symptoms, implications
and risks to self and other relatives, as well as knowing
what support is available); decisional control (having
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options or feeling able to make informed decisions for
managing genetic risk); behavioural control (feeling able
to actively use health and social services effectively to re-
duce harm or improve life situations for self, children and/
or at-risk relatives); emotional regulation (feeling able to
effectively manage the emotional effects of genetic dis-
eases, including coping and adjustment) and; hope (feeling
able to look to the future with hope for a fulfilling family
life for oneself, relatives and/or future descendants).
Third, the audit tool was chosen because, although it
cannot be used to measure pre/post change (because of
the way the items are worded), it is familiar to clini-
cians in the service (See Supplement C). It is referred to
by AWMGS staff as the ‘AWMGS satisfaction question-
naire’, although it might be more appropriately referred
to as a patient-reported experience measure. The audit
tool addresses six outcome areas (Skirton et al. 2005),
noted here with sample items: enhanced understanding
(e.g. I have more understanding of what causes the con-
dition); positive psychological change (e.g. I have great-
er peace of mind); respect for autonomy (e.g. My main
questions were answered); adaptation (e.g. I am more
able to ask for help if I need it); disequilibirium (e.g.
I couldn’t understand what I was told); and value of
contact (e.g. I felt treated as an individual). Responses
were measured on a seven point scale, indicating
strength of (dis)agreement.
Quantitative Participants, Procedures and Analysis
Following governance approval by the relevant hospital
Research and Development offices, quantitative PROMs data
were collected from patients before and after clinic attendance,
using GCOS-24 and EQ-5D 5-level version (Herdman et al.
2011; Janssen et al. 2013). These were mailed to all patients
having a first appointment at AWMGS between February and
July 2015 using approved informed consent procedures, and
enclosing a pre-paid envelope for return of the completed
PROMs pack. No demographic data were collected. If the
patient referred to the service was a child, his/her parent was
asked to complete the PROMs. Parents can be considered
‘patients’ in clinical genetics, as they may be at risk for having
an affected child in subsequent pregnancies. Following clinic
attendance, all patients who had completed and returned
GCOS-24 and EQ-5D before clinic attendance were sent a
second PROMs pack comprising GCOS-24, EQ-5D and the
audit tool (as previously noted, the wording of the questions
within this tool does not enable pre/post intervention evalua-
tion). PROMs responses were input into SPSS for Windows.
Data were analysed using descriptive statistics and repeated
measures analysis of variance. A Bonferroni correction was
used for multiple comparisons.
Communication with the Clinical Team
It was important that the clinical team was engaged with and
kept up to date with the process, and that discussions took
place about how the PROMs data might be useful.
Communication began with a seminar in September 2014 de-
scribing the plan for the study. The evaluation team met with
eight AWMGS clinicians, who had expressed an interest in
participating in the study, once every two months during the
data collection period (February–July 2015) to monitor prog-
ress. At these meetings, patient response rates weremonitored,
and discussions took place about how the PROMs data might
be useful.
Qualitative Participants, Procedures, Instrumentation
and Analysis
Following ethics approval from Cardiff University School of
Medicine, the eight AWMGS clinicians involved in the study
were invited to participate in an interview (using approved
informed consent procedures) to explore their perceptions
about the value and feasibility of using the PROMs data for
service quality improvement. The aim of qualitative research
is to explore the perspectives of human participants and it can
be used to gain an in-depth understanding of people’s views
about a given phenomenon or activity (Wengraf 2004).
Qualitative methods are suitable for exploratory research in
areas which are not entirely understood, where the participants
are actively involved in the generation of new healthcare
methods, and where some relevant variables have not yet been
fully identified (Wengraf 2004). As the purpose of this re-
search was to explore for the first time the perspectives of
AWMGS clinicians about the usefulness of PROMs data for
service quality improvement, a qualitative approach was ap-
propriate. Individual, face-to-face, semi-structured interviews
with participants were conducted. The interview guide (see
Supplement D) was developed by MM, and approved by the
National Institute for Social Care Health Research
Permissions Coordinating Unit (NISCHR PCU). ACT con-
ducted all the interviews and confirmed written consent from
all participants at the beginning of each interview.
Interviews were audio-recorded, transcribed in full and
analysed using thematic analysis, which permits identifica-
tion, analysis and reporting of patterns (themes) that appear
in qualitative data in order to identify common elements
across the interviews. Whilst the interview schedule was the-
matically structured it was exploratory in orientation. Thus,
the focus on challenges and benefits inherent in the research
questionmeant that analysis took account of themes across the
sections of the interview schedule. Data were thematically
analysed by the first author to ensure internal consistency.
Emergent themes were discussed and validated with the last
author. The analysis began by comparing the transcripts with
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the audio-recording to check that they were correctly tran-
scribed and familiarisation with the transcripts by reading
them several times. During this process, notes were taken
about initial ideas raised by the respondents relating to the
research question. As per Gioia et al. (2013), this initial stage
involved identifying first-order concepts, adhering to respon-
dents’ terms. The next stage involved developing second-
order themes, used as initial codes, by grouping respondents’
terms into thematically oriented meaning groups. As many
data as possible were codified, to enable the identification of
third-order aggregate dimensions (e.g. quality improvement,
patient-centred service), premised on classifying the codes
into larger groups (Gioia et al. 2013). These overarching find-
ings were then checked for relevance and consistency across
the dataset, as well as informativeness in relation to the re-
search question. This enabled refinement and further specifi-
cation of the aggregate dimensions.
Results
Quantitative Component
PROMs packs were mailed to 926 patients prior to clin-
ic attendance, and 213 completed PROMs packs were
returned, giving an initial response rate of 23%. Of the
213 patients who returned a pre-clinic PROMs pack, 96
(45%) also returned a post-clinic PROMs pack. This
resulted in 96/926 usable responses, premised on
matched pre and post clinic PROMs packs, giving a
final response rate of 10.3%. Statistically significant im-
provement in GCOS-24 scores following clinic atten-
dance (p < 0.05), with a medium-to-large effect size
(Cohen’s d = 0.64), demonstrated that patient benefits
were delivered. The mean pre-clinic GCOS-24 score
was 104.45 (SD = 16.5), and the mean post-clinic
GCOS-24 score was 115.33 (SD = 17.6). There was
no significant difference in the pre appointment ques-
tionnaire scores for those only responding to the pre
appo i n tmen t que s t i o nna i r e (mean = 105 . 41 ,
SD = 16.81) and those who responded to both
(mean = 104.45 SD = 16.544); t(200) = .405,
p = .686. A sub scale analysis was carried out using
repeated measures analysis of variance, comparing pre
and post appointment GCOS-24 scores for the seven
sub-scales. This analysis demonstrated that there was a
significant improvement in post appointment GCOS-24
scores for the hope, support, family impact, powerless-
ness, referral clarity and adaptation sub-scales but no
significant difference in the emotional regulation sub-
scale (See Table 2).
High post-clinic scores on the audit tool (mean = 95.5;
highest possible score = 126) also demonstrated good
outcomes, although there were no pre-clinic scores to compare
with. However, there was no significant change in EQ-5D
scores. The mean pre-clinic EQ-5D score was 21.61, and the
mean post-clinic score was 21.25 (p = 0.269).
Communication with the Clinical Team
Discussions with the clinical team focussed initially on
the disappointing response rates. A number of ap-
proaches to increasing the response rate in future exer-
cises were discussed e.g. PROMs to be made available
in the waiting room prior to appointments, and provid-
ing access to online versions of the PROMs that pa-
t ien ts could comple te us ing PCs, tab le t s and
smartphones. Discussions increasingly focussed on how
the PROMs data could be useful. Members of the clin-
ical team were not surprised by the lack of improve-
ment in scores seen on the EQ-5D, and their views on
this are reported in the qualitative analysis below. These
data were not felt to be useful for quality improvement.
The team was pleased by the GCOS-24 overall change
scores, and by the scores on the audit tool, and these
were perceived as cause for celebration. The group
agreed that it was useful to consider the overall sub-
scale scores. However, they were also keen to look at
change scores on individual GCOS-24 items to obtain a
more detailed insight into where patients were deriving
greater and lesser benefit. The GCOS-24 was felt to be
most useful because these data showed change in scores
following clinic attendance, which the audit tool did not
show. GCOS-24 change scores on individual GCOS-24
items following clinic attendance are shown in Table 2.
In keeping with the overall sub-scale scores, Table 2
demonstrates improvements in patients’ understanding of
their condition, their understanding of implications for
themselves and (specified) relatives, knowledge of
where to seek further help (educational, financial, social
support) and their feeling of hope and ability to make
plans for the future. Table 2 also shows that patients are
achieving fewer improvements in feelings of distress,
guilt, powerlessness, ability to cope and hope for their
children’s future. Consideration of the individual items
provides a little more insight than the sub-scale analy-
sis, which demonstrated lack of improvement in the
emotional regulation sub-scale only. These changes were
achieved following just one appointment, so any im-
provement is noteworthy.
Qualitative Component
Of the eight AWMGS health professionals who were
invited to participate, six agreed to be interviewed.
Two participants were consultants in clinical genetics
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(MDs in the UK context) and four were genetic coun-
selors (See Table 1). Recruitment and interviews were
carried out in May–June 2015. Although the number of
interviewees was small, some suggest that between six
and eight (Kuzel 1992) or six and twelve (Guest et al.
2006) participants can be sufficient for relatively homo-
geneous populations (in this case, longstanding depart-
mental colleagues). However, we acknowledge the ben-
efits of larger numbers to substantiate data saturation,
and the need for follow-on research from this explorato-
ry study. Nonetheless, thematic consistency was evident,
with no new major themes emerging in the final inter-
view. Three main themes were identified with sub-
themes in each: quality improvement (QI), patient-cen-
tered service, and use of PROMs.
Quality Improvement (QI)
All participants agreed that in order to assess whether
the service offered is of good quality, it is not sufficient
to assess only process measures (e.g. waiting times). It
is more important to evaluate the benefits obtained di-
rectly by patients, using a measure that could capture
patients’ perceptions before and after using the service.
Par t ic ipants a lso highl ighted that the NHS is
implementing use of PROMs to evaluate service quality
in other specialties. They also reported that evaluation
of CGS has focussed on process issues such as patient
complaints and compliments as well as waiting times,
but they argued that these measures provide no insight
into whether patient benefits are delivered (Table 2).
The ones that we’ve commonly used like patient
compliments, patient complaints, don’t really give a
very good overall view of how you’re doing (ppt 5)
…to have some sort of measure of outcome because
without a measure of outcome, just dealing with satis-
faction afterwards, people um, it’s not so helpful in de-
ciding what effect you have actually had (ppt 3)
It’s also probably institutionally necessary for us to use
them increasingly because we are likely to be required to
do so, to use some sort of patient-reported outcome
measure (ppt 3).
In supporting quality improvement, participants noted
that having additional detail regarding service users’
condition, reason for referral, and personal characteris-
tics would enhance the utility of the data, and scope to
tailor amendments in service provision.
So I think people’s expectation levels, depending
upon the client group, is going to be different and
I’m sure that will, or may, reflect in the answers
in terms of their satisfaction. So I think that’s
probably an important part of the analysis, if
you’re going to be able to identify which patient
group the respondents came from. (ppt 6)
Maybe it’s different in different appointments, different
conditions, or whatever, and then hopefully being able
to target, you know, whether perhaps in cancer sessions
maybe we spend too much time doing information and
we need to devote more time to psycho-social. (ppt 1)
Patient-Centred Service
In all interviews, the concept of patient-centeredness was one
of the strongest emerging themes either directly or indirectly.
Participants reported that the service itself and its quality
should be focused on the benefits and needs of AWMGS
patients. Participants explained that collecting PROMs data
could enable them to ensure the best possible patient experi-
ences and outcomes, thus ensuring patient-centred care.
Participants considered themselves to be patient-centered
health professionals, and also considered the administrative
team to be part of, and have invested in providing, a fully
patient-centered service.
Table 1 Sample characteristics
Participant
number
Type of genetics health
professional
Length of service in clinical
genetics
Length of service in
AWMGS
Area of specialism
1 Genetic counselor 8 years 5 years Cancer genetics
2 Genetic counselor 1 year and 3 months 3 months General genetics
3 Clinical geneticist 25 years 25 years General and cancer
genetics
4 Genetic counselor 3 years 1 year General genetics
5 Clinical geneticist 8 years 8 years General genetics
6 Genetic counselor 20 years 20 years General genetics
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We’re providing this service for the patients (ppt 2)
(the administrative team) are very patient-centred, you
know, they want to do the best for the patients that we
have coming into the clinical genetics service. (ppt 5)
By using these patient reported outcomes we can check
that we are actually meeting what they need from the
service and therefore hopefully deliver the best service
that we can […] the professionals here […] want to give
the best service they possibly can to patients and
therefore they are […] very willing to engage with qual-
ity improvements and with things that they can do to
ensure that they’re meeting patient needs (ppt 1)
Use of PROMs
All participants considered the use of PROMs appropri-
ate and necessary to evaluate patient outcomes, as well
Table 2 The Genetic Counseling Outcome Scale (GCOS-24): Change scores for GCOS-24 items and sub-scales











* p < 0.05)
8. I feel positive about the future. 0.344 0.024* Hope 1.281 0.007*
9. I am able to cope with having this condition in my family. 0.198 0.247
19. I am hopeful that my children can look forward to a rewarding family life. 0.271 0.167
20. I am able to make plans for the future. 0.469 0.005*
2. I can explain what the condition means to people in my family
who may need to know.
0.479 0.003* Support 3.094 0.000*
5. #I don’t know where to go to get the medical help I / my family need(s). 0.677 .008*
10. #I don’t know what could be gained from each of the options available to
me.
0.573 0.007*
15. I know how to get the non-medical help I / my family needs
(e.g. educational, financial, social support).
0.688 0.003*
16. I can explain what the condition means to people outside my family who
may need to know (e.g. teachers, social workers).
0.677 0.001*
4. #When I think about the condition in my family, I get upset. 0.156 0.443 Emotional
regulation
0.698 0.123*
11. #Having this condition in my family makes me feel anxious. 0.260 0.177
21. #I feel guilty because I (might have) passed this condition on
to my children.
0.281 0.193
3. I understand the impact of the condition on my child(ren)/any
child I may have.
0.531 0.020* Family impact 1.896 0.001*
12. #I don’t know if this condition could affect my other relatives (brothers,
sisters, aunts, uncles, cousins).
0.740 0.006*
18. #I don’t know who else in my family might be at risk for this condition. 0.625 0.015*
13. #In relation to the condition in my family, nothing I decide will change the
future for my children / any children I might have.
0.073 0.723 Powerless-ness 1.052 0.032*
17. #I don’t know what I can do to change how this condition affects me / my
children.
0.760 0.001*
22. #I am powerless to do anything about this condition in my family. 0.219 0.332
1. I am clear in my own mind why I am attending the clinical genetics service. 0.365 0.030* Referral clarity 1.292 0.004*
14. I understand the reasons why my doctor referred me to the clinical genetics
service.
0.469 0.013*
23. I understand what concerns brought me to the clinical genetics service. 0.458 0.007*
6. #§I can’t see that any good things have come from having this condition in
my family.
0.438 0.022* Adaptation 1.229 0.001*
7. I can control how this condition affects my family. 0.323 0.097
24. I can make decisions about the condition that may change my child(ren)‘s
future / the future of any child(ren) I may have.
0.469 0.027*
Based on estimated marginal means. Bold indicates p < 0.05
bAdjustment for multiple comparisons: Bonferroni
*The mean difference is significant at the 0.05 level
# Items reverse coded for analysis
§ Item wording reversed at the request of the clinical team from original wording ‘I can see that good things have come from having this condition in my
family’
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as a beneficial tool to enable them to think about ser-
vice improvements. GCOS-24 was considered useful by
the participants because it was validated specifically to
evaluate genetic counseling services, designed through a
systematic and logical procedure taking account of CGS
professionals’ and patients’ perspectives. GCOS-24 was
also valued because it could be applied before and after
the service to observe score changes.
It’s the one that’s been validated for genetic
counseling specifically, and therefore it seems to
me to be a good way to measure what we are
trying to do (ppt 1).
And those things are really specific to the genetic
counseling service and relevant and can be applied be-
fore and afterwards. (ppt 2)
… the questions repeated after the event so one would
hope that their expectations have been fulfilled, their
questions answered, hopefully their level of anxieties
reduced and their knowledge level has increased (ppt 6).
Participants also considered it important and useful to
evaluate patients’ experiences using the audit tool, when
applied together with a PROM. Participants appreciated
the audit tool because it was developed by a genetic
counselor, and because it includes some open questions.
(The audit tool) does cover some information and
in general we have found that patients have been
mostly satisfied. But that doesn’t tell us if we are
really necessarily meeting the needs of the patients
more specifically than that and so by using these
patient reported outcomes we can check that we
are actually meeting what they need from the ser-
vice (ppt 1).
Well it helps that it was made by somebody who’s fa-
miliar with the genetic counseling service. So I think this
would be a good one to use as well. (ppt 2)
So satisfaction questionnaires have their place but not to
look at the impact of what you have done in the clinic.
(ppt 3)
All participants reported that they perceived EQ-5D
as not useful to evaluate patient benefits from attending
AWMGS. Specifically, participants remarked that in
general, their patients are physically well and therefore
they considered most constructs captured by EQ-5D
irrelevant.
… about activities of daily living, I think that’s
completely irrelevant to it because most of our patients
are well (…) actually we don’t manage those difficulties
so it’s not relevant. (ppt 5)
The vast majority of our patients are kind of not ill,
they’re walking. So I think a lot of the questions are
not necessarily particularly relevant. (ppt 6)
Moreover, four of the participants explained that for
patients, it could be potentially confusing to be asked
the EQ-5D questions, because patients might think that
these questions are inappropriate for the type of condi-
tion they have.
I think people will be confused a bit about the EQ5D
because it’s, you know, not relevant to genetics counsel-
ing about whether they can wash and dress themselves
isn’t something we’re really concerned, well you know
that’s not to do with the treatments we provide really.
(ppt 4)
Nevertheless, most participants considered it neces-
sary to include EQ-5D in the PROMs set for this ini-
tiative because it is the generic PROM preferred by
NICE and to demonstrate that it might not be useful
for evaluating CGS. One participant was concerned that
using EQ-5D could make the CGS vulnerable. In the
future the NHS could allocate CGS funding on the basis
of patients’ EQ-5D scores, and the participant was con-
cerned that if a CGS did not show benefits using EQ-
5D, this could impact on future funding.
It’s important to include it to demonstrate that per-
haps that may not be the most useful one. (ppt 1)
So that could make us vulnerable. So if the health ser-
vice adopted the position that they exist to maximise
people’s EQ-5D scores then they would not want to
fund genetics verymuch because we probably have little
if any impact on EQ-5D. They would put the money into
treating arthritis, heart disease. (ppt 3)
Some participants voiced concerns that collecting and
reporting PROMs data might be experienced as threat-
ening both for the service and for some members of the
clinical team:
Everybody wants the scores to be good and to reflect
well on their practice […] a challenge could be that it
might be the opposite. So I guess there’s that challenge
of “Ooh, our practice has been looked at, and what if
comes up wanting?” (ppt 6)
I think that it is sometimes difficult to get negative re-
sults, I suppose personally and as a service. And I think
that’s a challenge for people, you know, this is very new
to us and I think so that is difficult, you know, to get
people to not take it personally but to think more that
this is an area where we can improve. (ppt5)
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The PROMs were perceived by participants as being gen-
erally patient-friendly and easy to understand. There was also
some concern voiced about the challenges that some patients
might have in completing the PROMs (e.g. patient with learn-
ing disability), but they also mentioned possible solutions. For
example, patients with learning disabilities could be afforded
support in answering the questionnaire, as described below.
if your patient has any degree of learning disability then
I think it becomes much harder so I think someone who
struggles with reading and writing would find it hard
[…] for someone else, to go through the questionnaire
with them and make sure, talk about each question
and be clear that they wanted to give a good score
or not so good score […] It’s better if it’s an
independent person if possible.
Regarding patient response rates, which were disappoint-
ing, participants were concerned that not all the patients had
the same availability or willingness to respond to question-
naires. As a result, the returned data might not be representa-
tive of all patients to whom the service was delivered.
Participants suggested that one way to increase patient partic-
ipation was to allow patients to respond to the questionnaires
using email or online questionnaires. Other proposed solu-
tions were to make the questionnaires available in clinic
waiting rooms on paper or using a tablet computer (iPad), or
for the administrative (admin) team to telephone patients to
remind them about the option to participate in the initiative.
I think to improve how you get it people have to be
able to do it instantaneously. So I do wonder, with
newer IT in mind, emailing questionnaires, you
know, or a survey that they can click straight to
and fill in, you know, like Survey Monkey, having
you know IT where you can ask and say, you know,
“Would you mind going onto this iPad?” (ppt 5)
[…] perhaps these could be given out in the clinic
setting or prior to the clinic or telephone contact
be made. (ppt 6)
Participants considered that the clinical team is best placed
to interpret the data, and brainstorm potential quality improve-
ment (QI) activities to address areas where the service could
be delivering greater patient benefits. They felt that the best
approach was for a small sub-group of the service’s clinical
staff to tackle the task of data interpretation, and then present it
to the full group in a meeting, for discussion of possible issues
that could be addressed using QI initiatives.
Once we’ve got the information you know from this
project, whether it would be perhaps that a smaller
group looks at it in the first place and comes up with
some suggestions for how we can do the quality im-
provement, and then taking that to the whole service
and getting people’s buy-in. (ppt 1)
So within that small group that would be, you know
that’s manageable, and then if we do suggest any chang-
es we’d have to go out to the wider team to discuss
implementation or you know how we’re going to bring
about those changes. (ppt 4)
Most participants said that the meetings should be
regular but flexible (approximately every 3–6 months),
allowing for periods of extra need or when data have
not dramatically changed. Regarding QI initiatives, there
was no clear consensus about how to address lack of
significant mean improvement in areas relating to pa-
tient’s reported emotional regulation. Some participants
advocated more clinic time to use their counseling
skills:
[…] the shorter an appointment is the less counseling
skills you can do, you know, you have to get through so
much information as well. (ppt 4)
Others advocated more counseling skills training:
And although we’ve had counseling skills training I
think there’s probably more work we could do, so better
training. (ppt 1)
Participants would like to use PROMs data in a cyclical
way e.g. Plan-Do-Study-Act cycles, with regular collection
and analysis of PROMs data, with appropriate steps taken to
address areas where patients are not benefitting as much as
they could be:
just getting everybody together, discussing the results,
discussing how we can make these results even better
for next time, and then hopefully re-doing it, like an
audit, re-doing the questionnaires with a different group
of patients and comparing whether the improvement, or
if there is an improvement first of all, and then if their
improvement is better than last time. (ppt 2)
There was no clear consensus on how the team could
best address areas where patients were deriving signifi-
cantly less benefit (patients’ feelings of distress, guilt
and powerlessness). Access to training in brief counsel-
ing interventions was made available to the clinical
team as a way of developing new skills in this area,
with a plan to collect further PROMs data 18 months
later. However, the significance of achieving discernible
difference in many PROMs items based on a single
consultation needs to be reiterated.
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Discussion
This study is the first study to explore usefulness of PROMs
data for quality improvement in clinical genetics services.
Findings demonstrate that PROMs were considered by
AWMGS health professionals who participated in the study
to be a good tool to measure the benefits to patients from using
the CGS, enabling direct capture of patients’ change scores
following clinic attendance. Of the questionnaires used in this
initiative, GCOS-24 and the audit tool were considered
useful and EQ-5D was considered significantly less use-
ful for evaluation of CGS. The main barrier encountered
to effectively using PROMs data for service QI was
poor patient response rates.
Because this is the first study exploring usefulness of
PROMs data for quality improvement in clinical genetics ser-
vices, findings cannot be directly compared with previous
studies. However, GCOS-24 was recently used in Vancouver
for evaluation of a psychiatric genetic counseling service
(Inglis et al. 2015). Although the Vancouver study was a ser-
vice evaluation without a quality improvement component
and did not seek to explore the perspectives of the profes-
sionals involved, the Canadian study also showed a significant
improvement in GCOS-24 scores after a genetic counseling
consultation, demonstrating usefulness of GCOS 24 for ser-
vice evaluation.
Regarding EQ-5D, although it has never before been re-
ported to evaluate CGS, this study is not the first time that this
PROM was considered unhelpful for evaluating a service be-
cause that service addresses patient outcomes that are not cap-
tured by EQ-5D (Phillips 2009; Wailoo et al. 2010). However,
without EQ-5D, it is not possible to calculate QALYs deliv-
ered to patients of CGS, limiting use of PROMs in economic
evaluations of CGS.
Findings in the current study support findings in a previous
study exploring healthcare professionals’ perspectives of
using PROMs to evaluate other healthcare services.
Specifically, a review of qualitative studies exploring
healthcare professionals’ views of using PROMs data to im-
prove healthcare quality (Boyce et al. 2014) found that partic-
ipants appreciated PROMs as a tool to complement their own
clinical judgment and encouraged their professional
development, a sentiment also expressed by respondents in
the present study. One concern reported in the Boyce et al.
(2014) review is the possible use of PROMs data to justify
cost-cutting. Similarly, one participant in the present study
expressed concern that the NHS might use this information
to justify cutting CGS resources. However, the present study
also demonstrated commitment amongst AWMGS clinical
staff to using PROMs data for the benefit of patients and for
their own professional development. The qualitative aspects
of this exploratory study also signal the importance of further
exploring the challenges faced by individual employees, who
reported responding to PROMs feedback on a personal, as
well as professional level. Furthermore, the finding that pa-
tients derived little benefit in the emotional regulation sub-
scale of GCOS-24, and the additional information from the
analysis of individual GCOS-24 items regarding fewer im-
provements in feelings of distress, guilt, powerlessness, ability
to cope and hope for their children’s future, may signal the
need for additional investment in counseling to address deeper
levels of emotional distress. GCOS-24 could be a useful tool
to evaluate any marginal benefit of additional counseling
sessions.
Study Limitations
The major limitation of this study is the low patient PROMs
response rate. The present study is not the first to report diffi-
culties in collecting PROMs data as a barrier to using PROMs
for service evaluation (Dunckley et al. 2005; Meehan et al.
2006; Slater and Freeman 2005). Other initiatives collecting
PROMs data routinely for service evaluation report the time
required for workers to input the data on computers as prob-
lematic (Abernethy et al. 2008). In the AWMGS study, this task
along with PROMs data analysis was completed by MSc in
Genetic Counseling students (DF & CT), and so these tasks
did not require completion by a member of AWMGS team.
Participants suggested online data collection and analysis may
be helpful in the future. However, these novel methods would
require investment. Studies show that the use of IT for PROMs
data collection (such as tablet computers in outpatient clinics) is
feasible and acceptable (Bennett et al. 2012; Tavabie and
Tavabie 2009). This could potentially mitigate the low response
rates. In addition, as data were collected and discussed by the
team, it became apparent that demographic data would have
been extremely helpful. Unfortunately, the governance arrange-
ments put in place at the outset of the study precluded their
addition. There is scope for future research to consider whether
the types of benefits derived by patients vary according to their
condition, reason for referral (e.g. families referred for paediat-
ric versus adult onset conditions; cancer genetic testing; carrier
testing), or personal characteristics. Furthermore, it is as yet
unclear how much change in GCOS-24 scores is important
and meaningful to patients. It will be important to establish
the Minimum Clinically Important Difference (MCID) (King
2011) for the GCOS-24, which is the smallest change in a
treatment outcome that matters to patients, or that patients
would identify as important. This will be useful for
interpreting GCOS-24 scores in future research, service
evaluation and quality improvement work.
A number of studies in other healthcare specialties (Appleby
and Devlin 2004; Dunckley et al. 2005; Hughes et al. 2004;
Meehan et al. 2006; Slater and Freeman 2005) reported that a
lack of collaboration between colleagues using PROMs could
be a barrier to effective implementation of routine PROMs
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assessment. However, this did not emerge in the AWMGS ini-
tiative; participants considered both themselves and the admin-
istrative staff very much engaged in the PROMs data collection
exercise, and as sharing the goals of wanting to provide patient-
centered care. Nevertheless, only a proportion of AWMGS clin-
ical staff participated in this study, and if PROMs assessment
should become routine, it may be worth monitoring whether all
staff continue to be invested and committed to this initiative
(and the factors that enable this), since staff involvement was
considered by participants to be fundamental to success.
A second limitation of this study is that the sample size was
also small in the qualitative study, and although it may repre-
sent the views of AWMGS clinicians, it is not necessarily
representative of CGS more widely. So while the themes that
emerged from the analysis are generally concordant with what
is reported in the literature, they cannot be extrapolated to
other CGS beyond AWMGS. However themes are still mean-
ingful because the present sample represents a majority of
AWMGS clinical staff involved in the PROMs QI initiative,
including both clinical geneticists and genetic counselors.
A third limitation of this study is the threat to internal validity
that is posed due to the lack of a comparison group who did not
attend the clinic. This study was designed as a before-after com-
parison, with the threat to internal validity mitigated since
GCOS-24 has established test-retest reliability (r = 0.86) and
responsiveness following attendance at a UK clinical genetics
service (effect size of Cohen’s d = 0. 70) (McAllister et al. 2011).
Despite these limitations, this study also has strengths.
Thematic consistency was evident across the interviews. The
context in which this project was developed is innovative for
using PROMs in CGS, and for comparing measures to other
assessments, notably the EQ-5D and GCOS-24. Although
PROMs (including GCOS-24) have been used for service
evaluation in CGS (Inglis et al. 2015), this is the first reported
example of PROMs data being used for quality improvement
in CGS. Furthermore, this study is the first to explore CGS
professionals’ views about using PROMs for continuous eval-
uation and QI of the service.
Practice Implications
Measuring PROMs routinely in clinical genetics practice and
sharing data through staff forums focused on discussing find-
ings and reflecting on any appropriate action to improve prac-
tice has potential to improve patient-centred care and maximise
patient benefits. Although this requires giving staff space and
time to step out of clinical activities, the participants in this
study found the exercise to be both rewarding and useful. It
represented an opportunity to celebrate areas of practice where
patients were gaining benefits, as well as identify some areas
where improvements could be made. As noted above, devel-
opment of online methods for data capture and automated data
analysis is likely to maximise patient response rates to PROMs.
Research Recommendations
Future research should take account of whether and how rea-
son for referral or demographic characteristics influence pa-
tient outcomes as measured by PROMs data. Futhermore,
additional research exploring factors supporting uptake of
PROMs amongst clinical genetics patients would be helpful
to establish whether patients consider PROMs to be a useful
way to provide feedback to clinical services, and what pro-
cesses could help to maximise PROMs response rates. It
would also be helpful to explore with clinical teams what
improvement skills they require to effect improvement, based
on PROMs feedback. This could identify potential training
needs and strategies for organisational support and, in time,
potential additions to education curricula.
The clinical team and the research team were pleased that
improvement was evident following only one appointment at
the clinical genetics service. It would be interesting for future
research to evaluate the marginal benefit of additional
counseling sessions, and the tipping point for emotional ben-
efit. Establishing the Minimum Clinically Important
Difference (MCID) (King 2011) for the GCOS-24, will be
useful for interpreting GCOS-24 scores in future research,
service evaluation and quality improvement work, and for
making a case for further investment in genetic counseling.
The present study explored usefulness of EQ-5D for eval-
uation of clinical genetics services, but this PROM was not
found to be useful. EQ-5D is favoured by NICE in the UK
because it has available preference weights to enable its use in
economic evaluations. For PROMs to be useful in economic
evaluations of clinical genetics services, it will be important to
develop a suitable preference-based PROM. Although
GCOS-24 has good psychometric properties (reliability, va-
lidity, responsiveness), it is currently unsuitable for use as a
measure of patient benefit in economic evaluations because it
is too unwieldy (long) with no available preference weights.
One approach to address this could be to identify five or six
GCOS-24 items and levels for valuation (creating GCOS-
short), and use health economics methods to identify and ex-
plicitly incorporate preference weights to reflect the relative
importance that people place on the specific GCOS-short
items and levels, and for these weights to be reflected in sum-
mary measures. This would facilitate future work to compare
alternative clinical genetics interventions aimed at promoting
patient empowerment, to better take account of the relative
benefits of the interventions for economic evaluation. It will
also be important to continue to work to identify a suitable
generic PROM for use in clinical genetics, since EQ-5D was
found not to be useful. ICECAP-Adult may provide a useful
alternative to EQ-5D (Al-Janabi et al. 2012; Sen 2007).
ICECAP-Adult was designed to capture the concept ‘capabil-
ity’ for use in economic evaluation, and comprises five do-
mains: attachment (ability to have love, friendship and
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support), stability (ability to feel settled and secure), achieve-
ment (an ability to achieve and progress in life), enjoyment
(ability to experience enjoyment and pleasure), and autonomy
(ability to be independent) (Al-Janabi et al. 2012; Sen 2007).
Conclusions
This study has demonstrated that use of PROMs, and in partic-
ular GCOS-24, was viewed positively by the AWMGS partic-
ipants for service evaluation and quality improvement. It also
demonstrates the general desire of AWMGS staff to evaluate
the service using PROMs routinely for QI. Over time it will be
important to demonstrate whether patients obtain greater bene-
fit from the possible improvements implemented in the service
based on the PRO data by repeating the initiative. PROMs data
will continue to be collected regularly by AWMGS, with mem-
bers of the clinical team analysing and reporting on the success
or otherwise of implementing additional training in brief
counseling interventions. This study has also identified poten-
tial enablers for using PROMs data for quality improvement
such as online data collection and automated data analysis,
although these initiatives will require initial investment.
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